Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Company announcement No. 50 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 39, 2026) Copenhagen, Denmark, September 28, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
To keep drug prices high, pharma has been piling up the patents
The cost of healthcare in general is a debilitating, pre-existing condition for Americans. But the high prices of prescription drugs usually stand out as a pain point. While there are many insidious reasons why Americans pay more—often far…
Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'White Spaces'
Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief…
Roche Focuses on Speed at Pharma Day
Roche provided a glimpse into its pipeline at its “Pharma Day.” (File photo) At its so-called “Pharma Day,” Roche sent a clear message to the market: The company intends to remain a top player. This applies to both the…
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
Sun Pharmaceutical Industries and LIB Therapeutics Inc on Monday announced an exclusive licensing agreement granting the Indian drug maker rights to commercialise and manufacture lerodalcibep worldwide, excluding the U.S. and China. The agreement…
Natco Pharma raises eGenesis investment to $16.70 million
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million. Under the revised…
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs
is investing $2 billion into Summit Therapeutics as part of an expanded partnership between the two companies. Summit said Monday that AstraZeneca will buy $2 billion of convertible preferred shares, representing a common stock price of $18.36 a…
HCAH, QMS merge pharma businesses to expand patient support services
Health Care At Home India Pvt Ltd (HCAH) and QMS Medical Allied Services Ltd (QMS) on Monday announced a strategic merger of their pharma businesses to drive their patient support program for pharmaceutical companies across India. Under the…
Oil, pharma enterprises and banks already migrating from hyperscaler to local cloud service providers: ESDS
Noting the strong push for sovereignty in India, oil, pharmaceutical companies, enterprises and banks have migrated from hyperscaler to local cloud service provider ESDS Software Solutions, as per company CEO Piyush Somani. Unaffected by the…
Torrent Pharma raises investment in Torrent Urja 27 to ₹11.88 cr to acquire 26% stake
Torrent Pharmaceuticals Ltd has increased its proposed investment in Torrent Urja 27 Pvt Ltd to ₹11.88 crore to acquire a 26 per cent stake, following an increase in project capacity, according to a regulatory filing on Monday. The company…
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 5.8% - What's Next?
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) rose 5.8% on Monday. The stock traded as high as $23.74 and last traded at $23.8850. Approximately 708,318 shares were traded during trading, a decline of 37% from the…
Sun Pharma inks global licensing pact with LIB Therapeutics for cholesterol drug Lerodalcibep
Sun Pharmaceutical Industries on Monday said it has signed an exclusive agreement with US-based LIB Therapeutics to manufacture, commercialise, and globally license Lerodalcibep in all markets outside the United States and China. Lerodalcibep is a…
AI at heart of Roche's future strategy
Teresa Graham, head of the pharmaceuticals division, said the Basel-based company had many promising potential blockbusters in its pipeline. While Roche was hit by research setbacks and revenue losses due to expiring patents in 2022, the group has…
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Q2 2026 Earnings Call Transcript
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Q2 2026 Earnings Call September 22, 2026 3:00 AM ET Yuqing Chen - Corporate Participant Zhi Huang - Senior VP, CFO & Co-President of the Innovative Drugs Business Unit Good afternoon…
New era for clinical trials: GBA platform showcases progress in dementia, cancer, and HIV studies
The Greater Bay Area International Clinical Trial Institute (GBAICTI) and the Greater Bay Area Clinical Trials Center (BAY TRIAL) on Monday introduced the latest progress under the “one institute, one center” collaboration model in…
Receive a Daily briefing on Pharma Industry News
Get Started